Executive Summary
This period's 28 contract exercises reveal $12.8B in long-term U.S. government commitments, dominated by NASA space propulsion and R&D awards to primes like Northrop Grumman ($4.4B to 2026), Boeing ($1.2B to 2027), and Lockheed Martin ($295M total to 2048), signaling bullish stability for aerospace despite execution risks. IT services and health/admin contracts to firms like Accenture ($1.56B total), CACI ($961M), and Novitas ($446M) provide multi-year revenue visibility through 2025-2031. Investors should prioritize space sector exposure for growth, monitor option exercises adding $3B+ potential, and flag subaward dependencies exceeding 90% in some cases like Booz Allen.
Tracking the trend? Catch up on the prior Contract Option Exercises digest from January 15, 2026.
Investment Signals(3)
- NASA space contracts lock in $7.6B+ through 2048(HIGH)▲
Ultra-long-term awards to Northrop, Boeing, L3Harris, Lockheed total $7B+ obligations with options to $9B+, mostly cost-plus for propulsion/R&D, ensuring stable revenue amid low outlays ($1.9B to date).
- IT services backlog builds to $3B+ multi-year(HIGH)▲
GSA/VA/DHS/SSA awards to Accenture, CACI, ECS Federal, Manhattan Telecom exceed $2.5B obligations (options to $5B+), with 60%+ outlays in mature contracts signaling execution momentum.
- Health construction/services hit $1.3B steady flow(MEDIUM)▲
HHS/VA contracts for EHRM, MAC processing, facilities to Hensel Phelps ($755M), Novitas ($446M), Dawes ($47M) show 50-75% outlays, full options exercised in key deals.
Risk Flags(3)
- Execution[HIGH RISK]▼
Long durations (avg 10+ years to 2048) with low outlays (e.g., $93M on L3Harris $1B; $0 on several $40M+)
- Execution[MEDIUM RISK]▼
Subawards >90% of value in 20% of contracts (e.g., Booz Allen $667M/97%; Gen Dynamics $294M vs $125M obligation)
- Market[MEDIUM RISK]▼
Firm-fixed-price (40% of value) exposes to overruns amid inflation/delays in construction/IT (e.g., Hensel Phelps $755M, Manhattan $132M)
Opportunities(3)
- ◆
$3B+ unexercised options (e.g., Lockheed GEOXO $2B potential; CACI $1.5B; ECS $429M) across space/IT
- ◆
Extensions to 2028-2048 in 15 contracts signal follow-ons in NASA space R&D, VA EHRM, CMS MAC
- ◆
Small/SDVOSB wins ($500M+ total, e.g., Serrato $43M 88% outlayed, Dawes $47M) offer M&A/scale-up upside
Sector Themes(3)
- ◆
60% of value ($7.6B) in non-competed/long-term cost-plus to 4 primes for SLS/GEO XO/DAVINCI, low outlays signal future ramps.
- ◆
25% of contracts ($3B+) for CDM/EHRM/ACE via GSA/VA/DHS, options double potential value.
- ◆
$1.8B in VA/HHS for EHR/construction/MAC to 2029, 60% avg outlays.
Watch List(3)
- 👁
{"entity"=>"Lockheed Martin (GEOXO $2.3B options)", "reason"=>"Largest upside ($2B potential to 2048) vs $263M obligated, early stage.", "trigger"=>"Option exercise announcements or NASA FY27 budget"}
- 👁
{"entity"=>"Northrop Grumman (Ares I-X $4.4B)", "reason"=>"$3.5B unoutlayed by 2026 end, sole propulsion play.", "trigger"=>"Outlay acceleration >$500M/quarter"}
- 👁
{"entity"=>"Small caps (Serrato, Dawes, EKAGRA)", "reason"=>"$130M+ high outlay/near-term execution, set-aside momentum.", "trigger"=>"Full obligation realization or M&A interest"}
Get daily alerts with 3 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 28 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC